Skip to Main Content


Distinguished Women

Women faculty and alumnae of YSM have made important contributions to science, clinical medicine, mentoring, and teaching. Since our goal is to be inclusive and to create a record of all women who have had an impact, we invite you to recognize faculty and alumae, current and past, alive or deceased, whom you feel exemplify excellence in science or clinical care and/or are role models, leaders, or mentors, as well as those who work or have worked on issues that affect women.

To recognize or honor a woman, you may provide professional information pertaining to her career, or you may simply want to offer personal thoughts or remembrances about how a mentor, colleague, advisor or friend affected your life or career.

Click here to recognize a colleague, mentor, or woman whom you admire.

  • Alumna

    Years active at Yale: YSPH Class of 1969Expertise and Public Health Practitioner, LeadershipSusan Addiss is being recognized for her expertise and leadership as a public health practitioner. She had an exemplary career in public health practice at the local, state, and national level. She was Commissioner of Health for the State of Connecticut from 1991 to 1995, heading up the Department of Public Health and Addiction Services (now the Department of Public Health). Prior to this she was director of the Quinnipiac Valley Health District from 1985 to 1991, served as chief of the Bureau of Health Planning and Resource Allocation at the Connecticut Department of Health Services from 1976 to 1985, and held various positions with local public health departments in the state. She is a member and past president of the American Public Health Association and the Connecticut Public Health Association, a founding member and current director of the Connecticut-based Environment and Human Health, Inc., a vice-chair of the Connecticut Health Foundation, and a past member of the Pew Environmental Health Commission.
  • Associate Professor of Emergency Medicine; Affiliated Faculty, Yale Institute for Global Health; Director, Global Health Education; Section of Global Health & International Emergency Medicine

    Years active at Yale: 2012-presentDr. Agrawal is being recognized as a nationally and internationally recognized scholar and leader in global health and academic emergency medicine. With extensive, first-hand experience providing technical assistance and evaluations to international NGOs engaged in humanitarian relief, Dr. Agrawal has worked around the globe from Japan to Cameroon. She is a tireless advocate for improving health outcomes among the world’s most vulnerable populations, with a particular focus on refugees. She has partnered with major NGOs to assess health outcomes upon resettlement for pediatric refugees and helped design tools for refugee resettlement agencies to rapidly identify the health needs of new populations. Dr. Agrawal epitomizes the catchphrase, “Think globally-act locally.” As a board member of the Integrated Refugee and Immigrant Services (IRIS) of New Haven, she has developed a community-based research program designed to improve the linkage between refugees in the New Haven community and health and social services. Beyond her scholarly work, Dr. Agrawal is a formidable educator and clinician in the Department of Emergency Medicine. She has mentored dozens of residents participating in the Yale/Stanford/Johnson & Johnson Global Health Scholars program, and has served as a faculty advisor to numerous residents and medical students. Dr. Agrawal is also an ardent advocate for women, serving as a member of the American College of Emergency Physicians’ Women in Global Health Initiative, and she was recently elected president of the Academy for Women in Academic Emergency Medicine, where she has served as chair of the Global Health Committee and as Treasurer. In 2018 she received the AWAEM Momentum Award in recognition of her extraordinary services in moving the mission and values of AWAEM forward. Awardees have enhanced the recruitment, promotion, retention, and advancement of women in academic emergency medicine through individual support as well as organizational influence. At YSM, Dr. Agrawal is faculty coordinator of the Emergency Medicine Global Health Day Symposium and a faculty member at the Yale Center for Asylum Medicine.
  • William H. Carmalt Professor of Surgery; Chair, Surgery

    Years active at Yale: 2018-presentDr. Ahuja is being recognized for her leadership and her excellence in clinical care and research. Dr. Ahuja is a passionate advocate for mentorship of trainees, staff, and faculty and has a reputation as a collaborative leader. Her surgical specialization is in gastrointestinal cancers, including gastric, rectal, and pancreatic cancers. She has developed an international reputation for management of peritoneal cancer metastases with cytoreduction and heated intraperitoneal chemotherapy, which attracts patients from around the world. She is widely recognized as a leader in translational epigenetics, conducting investigator-initiated clinical trials in colorectal cancer, pancreatic cancer, and other solid tumors. In addition, she has developed biomarkers for early detection of colorectal and pancreatic cancers. Dr. Ahuja is a national and international surgical leader and surgeon scientist who serves on multiple editorial boards and in national leadership positions including as a member of the American Surgical Association, the elected national representative to the Commission on Cancer from the Fellowship for the American College of Surgeons, and on the Association of American Medical Colleges Council of Faculty and Academic Societies Administrative Board. She has published over 200 papers and book chapters contributing to both the surgical and basic science fields. Her many awards and honors include the William J. Reinhoff, Jr. Scholar Award, the American Surgical Association Fellowship, the Society of Surgical Oncology Clinical Investigator Award, and the Abell Foundation Award: Johns Hopkins Alliance for Science and Technology Development.
  • Professor of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health

    Years active at Yale: 2002-presentSerap Aksoy, PhD, is being recognized for her excellence in research into the biology of host-pathogen interactions, specifically involving tsetse flies, which transmit African trypanosomes and harbor multiple symbiotic microbes. Dr. Aksoy has multiple collaborative research programs with institutions in Uganda and Kenya, and her lab is developing novel methods to reduce tsetse fly populations or their ability to transmit disease. In Uganda, she studies the epidemiology of Sleeping Sickness disease. In addition to her research studies, she has been involved in an international training program to expand research capacity in tsetse-transmitted diseases in African laboratories. In 2004, she led the establishment of International Glossina Genome Initiative under the auspices of WHO/TDR, that helped decipher the whole genome sequence of six tsetse species along with there microfauna and trypanosome parasites.During her time at Yale, Dr. Aksoy has headed the Division of Epidemiology of Microbial Diseases from 2002-2010. She also served as editor in chief of the journal PLoS Neglected Tropical Diseases (2007-2020), where she worked to build research and publication capacity for global neglected tropical diseases. She has chaired both the National Institute of Allergy and Infectious Diseases’ Vector Biology Study Section and the World Health Organization’s Special Programme for Research and Training in Tropical Diseases, Molecular Entomology BL5. She is an Elected Fellow of the American Society of Tropical Medicine and Hygiene and Entomological Society of America. She was elected to the National Academy of Sciences USA in 2021.
  • Alumna

    Years active at Yale: YSPH Class of 1941 Dr. Alexander is being recognized as a pioneering woman physician and public health practitioner. Born in Philadelphia in 1899, she was only 4 years old when her mother died, and at age 13, her father lost his once flourishing livery stable. She eventually won a scholarship to the University of Pennsylvania and to pay for her living expenses, she worked as a maid, a clerk, and a waitress. Dr. Alexander ranked second highest among medical aptitude test examinees after her entry into the Woman's Medical College of Pennsylvania. African American physicians were discriminated against in many medical institutions, and no Philadelphia hospital would accept her for practical training. She moved to Kansas City for her internship and within a few years, she was back in Philadelphia, running her own community health clinic and serving on the faculty of the Woman's Medical College of Pennsylvania. The Aspiranto Health Home was founded in her own home to serve Philadelphia's poor.In 1941, Dr. Alexander earned her MPH at Yale and accepted a position at Howard University, where she was appointed physician- in-charge of women students. She also ran a private health practice and worked for the U.S. Department of Health. When World War II broke out, physicians from across the country were dispatched to military bases to care for the injured, leaving many groups at home desperate for medical care. Dr. Alexander volunteered for the government and was sent to the coal fields of Alabama to treat miners living in extreme poverty. She died at the age of 49 from lupus.
  • Professor of Medicine (Geriatrics) and of Biostatistics; Leader, Data Management and Statistics Core, Yale Alzheimer's Disease Research Center, Internal Medicine; Co-director of the Biostatistics and Bioinformatics Core of the Yale Transdisciplinary Collaborative Center for Precision Medicine focused on Health Disparities

    Years active at Yale: 2000-presentDr. Allore is being recognized for her outstanding contributions to clinical science and leadership. She is director of the biostatistics core of the Yale Program on Aging and has pioneered advanced methodological applications for overcoming issues inherent in aging research. She is credited for founding the field of "gerontological biostatistics."
  • Former YSM faculty

    Years active at Yale: 1933-1950 Dr. Ames is being recognized for her significant role in research on and popularization of norms of child development. Dr. Ames became the best known of several women MDs and PhDs who collaborated with Arnold Gesell, MD, director of the Clinic of Child Development at Yale from 1911 to 1948. The women members of the clinic included Catherine Strunk Amatruda, MD (1903-1949), Frances Ilg, MD (1902-1981), and Helen Thompson, PhD. Dr. Gesell and his team studied detailed stages of normal development of children by analyzing frames of film taken of children placed inside an experimental dome, which enabled the children to be viewed from outside. The collaborators did almost all the analysis of frames upon which the norms of development were based, and co-authored many of Dr. Gesell’s books. Dr. Ames came to Yale as a PhD student in 1933. Her thesis was on the sequence of prone progression in the human infant. She collaborated on such works as The First Five Years of Life (1940) and Infant and Child in the Culture of Today (1943), and also published research articles on her own. She, like Dr. Gesell, took a biological approach to child development (as opposed to behaviorism or psychoanalysis) and believed that stages of motor and cognitive development were predictable. She was particularly interested in tests for “developmental diagnosis” and age-related responses to Rorschach tests. In 1948, Drs. Ames, Ilg, and Janet Learned Rodell, founded the private Gesell Institute for Human Development in New Haven. She and Ilg, in addition to ongoing research, published books on child development for a general audience. They also wrote a syndicated newspaper column, called “Child Development,” and later, “Parents Ask,” from 1951 to 1996. Dr. Ames lectured widely and hosted a weekly TV talk show in the 1950s and 1960s.
  • Professor of Pharmacology and of Molecular Biophysics and Biochemistry; Co-Leader, Developmental Therapeutics, Yale Cancer Center; Co-Director Therapeutics/Chemotherapy Program

    Years active at Yale: 1992- presentDr. Anderson is being recognized for her leadership in mechanistic enzymology and structure-based drug design. Her work focuses on understanding how enzymes, playing critical roles in such diseases as cancer and infectious diseases, including AIDS, work at a molecular level. She uses that information to develop new drug therapies. Her recent work on new antiviral therapies to treat HIV infections in a long-term collaborative effort with Dr. William Jorgensen in Yale’s Department of Chemistry has led to the discovery of a promising preclinical candidate that is now under further development. Dr. Anderson has trained more than 40 graduate students and postdoctoral fellows who are now involved in biomedical research. She is a co-director of Developmental Therapeutics in the Yale Comprehensive Cancer Center, and co-track director of Biochemistry, Quantitative Biology, and Structural Biology in the Yale Combined Program in the Biological and Biomedical Sciences. Dr. Anderson has received numerous awards, including Monsanto Research Achievement awards, the Dean’s Young Faculty Award, the Hull Cancer Research Award, YCC Breast Cancer Initiative Award, Gates Foundation Grand Challenge Award, and Department of Defense Lung Cancer Concept Award. She has published more than 200 research papers and was elected to the Connecticut Academy of Science and Engineering.
  • Professor; Special Advisor to the Associate Dean for Student Affairs, Medical Education

    Years active at Yale: YSM Class of 1990, MPH Class of 1991; 1998-presentDr. Angoff is being recognized for her leadership in student affairs and the creation of educational programs which emphasize professionalism. Her leadership and programs have changed the ethos of our school and enriched the environment in which our students learn.She has been a tireless advocate for students, having created the Peer Advocate program which provides first-year students with upper-class student advocates and the Academic Advisor Program, which provides each student with an advisor who mentors and guides the student’s academic progress. She herself is an incredible mentor. Several of our more well-known students attribute their success to the advice and mentorship of Dean Angoff. Of equal importance to our school, Dr. Angoff has developed important elements of our educational curriculum which help form the professional identity of our students. They include: “The First Day of School” project, in which students are immersed in the importance of cultural humility, and “Power Day,” in which students and interdisciplinary faculty reflect on the meaning of power in medicine. Most recently, Dr. Angoff has become the Director of the Master Course which begins medical school exploring professional behavior through hospital emersion, reflective writing, and other exercises. Her mentorship of students, development of the Students Advisor Program and creation of curricula that emphasize the meaning of being a doctor have been significant and important contributions to our medical school.
  • Associate Professor Term; Project Director, Connecticut AIDS Education & Training Center; Director, Yale Infectious Disease Ambulatory Services, Infectious Diseases; Medical Director Nathan Smith Clinic, Infectious Diseases; Program Director, HIV Primary Care Training Track, Internal Medicine

    Years active at Yale: 2000-presentDr. Aoun-Barakat is being recognized for her deep and unyielding commitment for the past 20 years to bringing high quality, compassionate, and comprehensive care to people living with HIV. As medical director of the Yale New Haven Hospital Nathan Smith Clinic since 2010, she is a constant inspiration for her trainees and colleagues alike as she fosters team-bases care with excellence. She also created the robust HIV track within the primary care residency program in 2011 to promote development of future leaders in this area.
  • Senior Research Scientist Emeritus of Epidemiology (Microbial Diseases)

    Years active at Yale: 1968-1997 Dr. Armstrong is being recognized for her studies of retroviruses and her service as an administrator overseeing the university’s animal care committee. She also served on the Yale Biological Safety Advisory Committee and was acting vice-chair of the Department of Epidemiology and Public Health from 1993 to 1995. Dr. Armstrong’s early career focused on the study of retroviruses in mouse models. In the early 1980s, with the appearance of AIDS, a retrovirus, she turned to the study of Pneumocystis carinii pneumonia. Before retroviral therapy it was a common cause of death in AIDS patients. Dr. Armstrong studied the in vitro cultivation of Pneumocystis carinii, an opportunistic protozoon pathogen, and the delineation of the pathogen’s interaction with host lung tissue. Her research led to about 40 papers and reviews. In 2015, she was inducted into the Winslow Centennial Honor Roll for Excellence and Service, which was established to honor 100 alumni and/or faculty who made outstanding contributions to public health during the Yale School of Public Health’s first 100 years.
  • Associate Professor of Pediatrics (Emergency Medicine) and of Emergency Medicine; Affiliated Faculty, Yale Institute for Global Health

    Years active at Yale: 1999-presentDr. Arnold is being recognized as a leader in global child health education and training, and collaborative multi-sector partnerships to improve global maternal and child health (MCH). She is internationally recognized for her contributions to global health capacity building, professional leadership development, and scale up of proven interventions through existing MCH platforms to reduce child mortality through professional societies and initiatives, such as Rwanda’s Human Resources for Health Program, and the Survive and Thrive Global Development Alliance.At Yale, Dr. Arnold is a long-standing member of the Down’s International Fellowship Committee, helped create the Yale Pediatric Global Health Track, and actively mentors students, trainees, and junior faculty interested in global health. On a national level, she served as chair of the American Academy of Pediatrics Section on International Child Health (SOICH). Under her leadership, SOICH established an annual scientific abstract program for global health scholarship and travel grants for physicians from low- and middle-income countries to present their work at professional meetings, as well as prioritized global health advocacy training and policy work. Dr. Arnold has moderated congressional receptions focused on global MCH funding; participated in multiple high-level MCH events at the United Nations, NIH, and on Capitol Hill; and is frequently invited to speak both nationally and internationally about the importance of global capacity building and effective multi-sector bidirectional partnerships.Dr. Arnold is immediate past chair of the American Academy of Pediatrics Section on International Child Health, a member of the American Board of Pediatrics Global Health Task Force, and the North American representative to the International Pediatric Association, where she is co-chair of the Ethics Committee.
  • Albert E. Kent Professor of Neuroscience and Professor of Psychology; Member, Kavli Institute of Neuroscience at Yale University

    Years active at Yale: 1987-presentDr. Arnsten is being recognized for excellence in research and teaching. She is an international expert on the molecular regulation of the newly evolved brain circuits that subserve higher cognition, which are the target of such disorders as schizophrenia and Alzheimer’s Disease. Much of her work focuses on the prefrontal cortex, a newly evolved brain region that creates our "mental sketchpad," and subserves abstract reasoning, high order decision-making, working memory, and thoughtful regulation of attention, behavior, and emotion (including inhibition of inappropriate thoughts, actions and feelings). Her research has shown that exposure to uncontrollable stress or advancing age weakens network connections by opening ion channels near synapses, leading to loss of neuronal firing and cognitive impairment. Her work has successfully translated to new treatments for cognitive disorders in humans, including guanfacine (IntunivTM) for the treatment of attention deficit hyperactivity disorders and related prefrontal cortical disorders, and prazosin for the treatment of post-traumatic stress disorder. Dr. Arnsten has held MERIT and Pioneer Awards from the National Institutes of Health, and was awarded the 2015 Goldman-Rakic Prize for Outstanding Research in Cognitive Neuroscience. She is a member of the National Academy of Medicine.In addition to her research, Dr. Arnsten is a prize-winning teacher who has taught Yale medical students, graduate students, and undergraduates, as well as medical residents and fellows. She teaches about the neurobiology of mental illness with the hope that it will help reduce stigma. Her research on stress has also led to new programs aimed at de-escalating potentially violent situations by restoring higher brain functions during threatening conditions.
  • Assistant Professor of Emergency Medicine and Trauma

    Years active at Yale: 2012-presentDr. Aydin is being recognized for her accomplishments in the field of emergency medicine education and trauma/surgical critical care. She practices as an attending in the Emergency Department (ED) and the Surgical Intensive Care Unit (SICU). She is a also the Medical Director of SkyHealth and the inaugural Medical Director of the YNHH Adult Ground Critical Care Transport (CCT) program. She has served on multiple national society boards, and is an invited national and international speaker for various topics in Emergency Medicine and Critical Care.
  • Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center For Innovation In Global Health, Professor Of Medicine, Stanford University; Senior Fellow At The Woods Institute

    Department: Internal MedicineYears active at Yale: 1977-2009Dr. Barry is being recognized because of her expertise in international health and leadership in creating change for women at the School of Medicine. While on the faculty she rose to the rank of professor of medicine before she was recruited to Stanford University as senior associate dean for global health and director of the Stanford Center for Innovation in Global Health. She is a past president of the American Society of Tropical Medicine and Hygiene and was elected to the Institute of Medicine in 2002.While at Yale, Dr. Barry was a tireless advocate for women’s rights. She wrote the first policy to be used for maternity leave in the Department Medicine. In 2000,she and Dr. Shirley McCarthy co-authored “Recommendations for Addressing Inequity Issues at Yale Medical School,” more commonly called the Bill of Rights for Women. Dr. Barry was also passionate about her work in international health. She started the first International Health Clinic at Yale, along with Dr. Frank Bia, and they obtained funding from Johnson & Johnson to launch the first international residency training program at Yale. Our loss was Stanford’s gain.
  • Former YSM faculty

    Department: Department of Psychology, Department of Surgery’s Section of OtolaryngologyYears active at Yale: 1970-2005Dr. Bartoshuk is being recognized for her research in the studies of genetic variations in taste perception and how taste perception affects overall health. She is one of the world’s foremost authorities on the sense of taste. Now at the University of Florida, Dr. Bartoshuk is best known for her discovery, in the early 1990s, that one in four people is a “supertaster” for whom sweet is more cloying and bitter, more astringent. She was the first to discover that burning mouth syndrome, mostly experienced by postmenopausal women, is not a psychosomatic condition, but caused by damage to the taste buds at the front of the tongue. She was elected a Fellow of the American Academy of Arts and Sciences in 1995, and in 2003 she was elected to the National Academy of Sciences.Dr. Bartoshuk began her career in astronomy as an undergraduate at Carleton College in Minnesota, but left that field when her professors told her it was not friendly to women and that landing a position at an observatory would be nearly impossible for her. She changed majors when she learned that the psychology department would accept her math and science credits.
  • William H. Fleming, M.D. Professor of Molecular Biophysics and Biochemistry and Professor of Genetics and of Therapeutic Radiology

    Years active at Yale: YSM Class of 1988; 1993-presentDr. Baserga is being recognized because of her excellence in basic science research, in teaching and mentoring, and for her contributions to the history and progress of women at the school. A graduate of Yale College and YSM, Dr. Baserga has served in many leadership roles in the MD/PhD program as well as in her own department, including director of medical studies in the Department of Molecular Biophysics & Biochemistry,and program director in the Predoctoral Program in Cellular and Molecular. She has received many awards for her science and teaching including the “Bohmfalk Scholar in Medical Research,” and the Charles W. Bohmfalk Prize for basic science teaching. She was elected to the Connecticut Academy of Science and Engineering in 2012. Dr. Baserga has also been an advocate for women and the issues that affect them. In the 1980s and 1990s, she worked with the Committee for the Status of Women in Medicine, helping to create policy that increased day care options, pressed the dean to hire more women, and published yearly transparency documents for faculty salaries. The first sexual harassment guidelines at Yale University were written at that time by Dr. Baserga and this committee. Dr. Baserga’s science, teaching, and women’s advocacy constitute important contributions to our school.
  • Professor of Internal Medicine (General Medicine); Section Chief of General Internal Medicine VA Connecticut Healthcare System; Director, Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center

    Years active at Yale: 2016-presentDr. Bastian is being recognized for her excellence in clinical science and leadership. She is a health services researcher whose research focuses on developing health behavior interventions. Since joining the faculty in 2016, she has served as section chief for General Internal Medicine and director of Pain Research, Informatics, Multimorbidities, and Education (PRIME) at the VA Connecticut Healthcare System. She has a long-standing interest in health behaviors among women veterans. She began her research career in women's health in 1991 at Duke University, where she served as the medical director of a comprehensive women's clinic and also served as PI of NIH and VA grants focusing on interventions to change health behaviors,such as smoking cessation and weight loss. She has served as deputy editor of the Journal of General Internal Medicine since 2006. Her scholarly accomplishment is demonstrated by more than 150 publications in peer-reviewed journals. In her leadership role as director of the PRIME Center, she oversees a health services research program with 30 core faculty and she mentors both fellows and junior faculty.
  • Alumna

    Years active at Yale: PhD Class of 1932; MD Class of 1934Dr. Baumgartner is being recognized for her role as a pioneering woman in public health. She was an early recruit to the Yale Plan of Medical Education. Induced to undergo two years of general medical training and an internship rather than remain immersed in basic immunology, she found a place for her expanded interests as a national leader in public health. Values promulgated by C-E.A. Winslow and Ira Hickok of the Yale School of Public Health became the bedrock of her career. She eventually became Commissioner of Health for New York City, where she spearheaded the creation of the Health Research Council (meant to be a National Institutes of Health for NYC), developed programs for drastically reducing the infant mortality rate, improved sanitation, and linked clinical medicine to public health in new and effective ways. Under her direct leadership, NYC enrolled in the Salk vaccine trial of 1954, which led to the near elimination of polio in the city over the course of three years. Dubbed by Life Magazine as “Doctor to 8,000,000 People,” she went on from the Health Department to become an assistant secretary of state, the highest ranking woman in the Johnson administration. She ended her distinguished career as Visiting Professor of Social Medicine at Harvard.
  • Professor of Pediatrics (Emergency Medicine) and of Emergency Medicine

    Years active at Yale: 1999-presentDr. Bechtel is being recognized for her dedication to the well-being of children and adolescents. She is medical director of the Pediatric Sexual Assault Nurse Examiner (SANE) Program; chairperson of the Yale Traffic Safety Subcommittee; co-chairperson of the state of Connecticut Child Fatality Review Panel; and co-principal investigator of the Injury Free Coalition for Kids at Yale New Haven Children's Hospital. She received her medical degree from the University of Medicine and Dentistry of New Jersey-Rutgers Medical School; completed her pediatric residency at St. Christopher's Hospital for Children, and completed her fellowship training at Children's Hospital of Pittsburgh. She has been on the faculty at Yale School of Medicine since 1999.Dr. Bechtel’s academic career has focused on the social welfare and medical well-being of children and injury prevention. Her clinical research has focused on the evaluation of children with head trauma; the prevention of abusive head trauma; recognition of child abuse and neglect by emergency medical service providers; the evaluation of children and adolescents after sexual assault; the evaluation of children and adolescents who are involved in domestic minor sex trafficking; the prevention of traffic injury; and the prevention of post-traumatic stress symptoms in children with traumatic injury.She was honored by Yale University and the City of New Haven with the Seton Elm Ivy Award in 2015 for her work to prevent traffic injury.
  • Former YSM faculty

    Department: School of Public Health Years active at Yale: 1979-1995Dr. Berkman is being recognized because of her research in epidemiology and inequities of health care delivery due to social and race inequities. During her 16 years on the Yale faculty, Dr. Berkman headed the Division of Chronic Disease Epidemiology and the Division of Health Policy at the School of Public Health. Now at the Harvard T.H. Chan School of Public Health, she is an internationally recognized social epidemiologist who studies social and policy influences on health outcomes. She seeks to understand inequalities related to socioeconomic status, different ethnic and racial groups, and social networks, support and isolation.At Harvard, she is director of the Harvard Center for Population and Development Studies, director of the PhD Program in Population Health Sciences and the Thomas D. Cabot Professor of Public Policy, Epidemiology, and Global Health and Population.
  • Associate Professor of Medicine (General Medicine)

    Years active at Yale: 2002-presentDr. Berland is being recognized for a unique and distinguished career path that has combined the practice of medicine with media. As an example, she has combined her long-standing interest and experience in the use of the documentary film format as a means to explore the experiences of patients. One film, “Rolling,” which documents the experiences of persons using wheelchairs, aired on PBS. This project was part of the reason she was recognized as a MacArthur Fellow, the first at Yale School of Medicine.At Yale, Dr. Berland has excelled at mentoring medical students who have an interest in this area, helping them produce short documentaries. She teaches two highly regarded courses at Yale College, each devoted to the exploration of how media can impact health. Her extraordinary mentorship across the university has enabled students to pursue novel scholarly projects, which has led to an expansion of what the university views as scholarly work. Currently an associate professor in the Department of Internal Medicine in the Section of General Internal Medicine, she is a practicing general internist. She has lectured nationally and internationally and has received achievement awards from her college, medical school, and residency-training program, many of which recognize her ability and courage to use novel approaches to scholarship.
  • Former YSM faculty

    Department: Internal MedicineYears active at Yale: YSM Class of 1979; 1986-2008Nancy Berliner, MD is being recognized for her excellence in basic and clinical research.  Currently she is a Professor of Medicine at Harvard Medical School and senior attending physician at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr.Berliner was in the Hematology Section, Dept.Medicine at YSM where she rose to the rank of Professor of Medicine and Genetics.She was a consummate clinician and teacher while doing basic research centering on the genetic defects in neutrophils that cause myelodysplasia and leukemia. She is a member of the American Society for Clinical Investigation, the Association of American Physicians, the American Clinical and Climatological Society, and the Interurban Clinical Club, and is a fellow of the American Association for the Advancement of Science and the American College of Physicians. She was President of the American Society of Hematology in 2009 and was elected to the Institute of Medicine in 2011.Dr.Berliner is the embodiment of a “triple threat” –great researcher; clinician and teacher. In addition to her outstanding reputation in academic medicine, she has always an outspoken advocate for women’s issues and gender equity.
  • Professor Emeritus of Medicine (Nephrology)

    Years active at Yale: 1978-presentDr. Bia is being recognized for her excellence in medical education, her leadership in transplantation, and her advocacy for women’s issues. A self-taught transplant specialist, she became the Yale School of Medicine’s first director of transplant nephrology in 1984, a post she held until 2001. She was recognized with the “Pioneer in Transplant” award from the National Kidney Foundation in 2004. She was the first woman invited to join the Nephrology Board of the American Board of Internal Medicine (ABIM), where she served from 1996 to 2002. Dr. Bia served another 11 years on the ABIM’s Self-Assessment Nephrology Committee. In medical student education, she directed the renal module from 1985 to 1998, becoming director of all the modules (the pathophysiology course) from 1998 to 2002. She created the Clinical Skills Program in 2001 and ran the program until 2014.Dr. Bia has won numerous teaching awards including: The Bohmfalk teaching prize for clinical sciences; the Francis Blake teaching award (twice); the dean’s award for exceptional contributions to the school; the Leah Lowenstein teaching award (twice); the AAMC Humanism in Medicine Award; and the House-Staff Teaching Award. Most recently, she was honored with a named teaching prize, the “Dr. Peggy Bia Award for Outstanding Clinical Teaching,” given to residents by the third-year class for outstanding teaching on the internal medicine clerkship. She has authored more than 100 peer-reviewed publications. For decades Dr. Bia has been active on The Committee on the Status of Women in Medicine (SWIM) and senior faculty committees, which promote issues that affect women. In 2018, she was honored with the Life Time Achievement Award from the National Kidney Foundation, Connecticut branch.
  • Years active at Yale: 2015-presentDr. Blakley is being recognized for her excellence in teaching and mentoring. She has been a fantastic supervisor and mentor. Dr. Blakley provides thoughtful and professional supervision within the Clinical Health Psychology program for interns and postdoctoral fellows. Trainees know firsthand that she works hard to offer hopeful and positive messages about caring for veterans. Dr. Blakley models ethical care for veterans and through her example, encourages excellence. In her current role in the Palliative Care Service, she provides compassionate care for veterans and their families. She is always willing to learn new skills and apply those wholeheartedly in her work.
  • John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging; Director, Mood Disorders Research Program

    Years active at Yale: 1998- presentDr. Blumberg is being recognized for her accomplishments in research and as an inspiration to women and men to work their hardest while maintaining friendships and family ties. Dr. Blumberg is well known for her pioneering work in youths with bipolar disorder (BD). This has included research evidence of differences in the trajectories of development of the brain circuitry during adolescence that has shaped the view of BD as a disorder of neurodevelopment and of adolescence as an important period. More recent areas of study include some of the first multi-modality research on the brain circuitry of suicide risk in adolescents and young adults, as well as changes in the brain in BD with age later in life, and with her Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART) psychobehavioral treatment. Dr. Blumberg’s research brings affected families hope that there may soon be new methods for early detection, targeted treatments, improved prognosis, and prevention of BD progression and suicide.Dr. Blumberg, who characterized one of the first demonstrations of brain differences in individuals experiencing manic symptoms of BD, has received the Colvin Prize for Outstanding Achievement in Mood Disorders Research.
  • Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

    Years active at Yale: 1989 - presentDr. Bockenstedt is being recognized for excellence in clinical medicine and for promoting diversity and equality at YSM. Dr. Bockenstedt received her undergraduate degree in chemistry and physics from Harvard College and her medical degree from the Ohio State University School of Medicine. After her residency in medicine at Yale, she completed clinical and research fellowships in rheumatology at the University of California, San Francisco. She returned to Yale as a faculty member in 1989, became assistant professor in 1991, and served as director of the Section of Rheumatology Training Program in Investigative Rheumatology from 1995-2004, leading it through its last ACGME accreditation in 2004. Dr. Bockenstedt leads a research program focused on the immunopathogenesis of tick-borne diseases with rheumatologic relevance, especially Lyme disease. She has mentored postdoctoral and medical trainees and gained international recognition for her studies of the host response to spirochetal infections. Her current research employs a systems biology approach to understand the diverse clinical manifestations of Lyme disease, and uses molecular profiling to identify host factors that underlie the divergent outcomes from this infection. For her teaching and clinical excellence, she was awarded the Howard M. Spiro Young Faculty Teaching Award and has continually been on the Best Doctors list since 2002. She is also a recipient of the Sir William Osler Young Investigator Award. She presently serves as co-chair, representing the American College of Rheumatology, of the Trisocieties’ (American College of Rheumatology, Infectious Diseases Society of America and American Academy of Neurology) effort to updates guidelines for the diagnosis and treatment of Lyme disease. Dr. Bockenstedt is an elected member of the Connecticut Academy of Science and Engineering. In 2006, she was named director for professional development and equity at YSM. In 2014, she was appointed associate dean for faculty development and diversity and chaired the YSM Ad Hoc Task Force on Gender Equity. In 2017, she became deputy dean for faculty affairs, where she is working to improve climate and support for the advancement of all faculty.
  • Assistant Professor

    Years active at Yale: 2012-presentDr. Bod is being recognized for her outstanding contributions to medical student education and promoting diversity at YSM. She helped to develop a combined emergency medicine/ultrasound sub-internship track for advanced rotators, and she helped to develop and implement a program to increase the recruitment of underrepresented minority students in emergency medicine. She is also a member of the Dean’s Advisory Council for LGBTQ Affairs.
  • Former faculty

    Department: Internal MedicineYears active at Yale: 1961-1978Dr. Bodel is being recognized as a gifted scientist, a beloved mentor to students, and an international leader in the study of fever. She came to Yale in 1961 as a research assistant and later joined the faculty, where she conducted research on the experience of women in medicine, challenging the notion that women were less likely than men to persevere and succeed in their medical careers. Writing in the journal Clinical Medicine in 1972, she and co-author Elizabeth Short, MD '68, laid much of the conventional wisdom to rest. (Their work is described in the book Medicine at Yale: The First 200 Years, published in 2011.)The data they collected led to an increase in the number of women admitted to YSM and better opportunities for women on the faculty. Dr. Bodel become the first director of the school’s Office for Women in Medicine—the first such office at an American medical school—and helped guide the medical school into a new era. Tenure rules were changed, allowing women more time to achieve tenure as they began families. Measures were put in place to correct gender disparities and to provide social and professional support. One example of this was increasing access to childcare.The Phyllis Bodel Childcare Center has had a tremendous impact on the careers of faculty, students, and staff at the medical school by providing a safe and stimulating environment for their young children right on campus.
  • Professor Emeritus of Emergency Medicine

    Years active at Yale: YSM Class of 1984; 1989-presentDr. Bogucki is being recognized for her research and program development in Emergency Medical Services (EMS) and disaster planning and response. She graduated from YSM in 1984 and joined Yale’s Department of Emergency Medicine in 1989. She holds several positions of leadership in the fire service and emergency medical services communities. She's a principal member of the National Fire Protection Association Technical Committee of Fire Department Health and Safety, and has conducted on-site investigations of fire fighter line-of-duty deaths for the National Institute for Occupational Safety and Health. Dr. Bogucki is also on the editorial board of Pre-hospital Emergency Care and was an associate editor of Academic Emergency Medicine. She is a past chairman of the board of directors of the National Registry of Emergency Medical Technicians, and was a senior medical advisor to the assistant secretary for Preparedness and Response in the U.S. Department of Health and Human Services from 2004-2008, participating in the federal medical response to major disasters.
  • Professor of Dermatology; Vice Chair, Clinical Affairs

    Years active at Yale: YSM Class of 1980; 1980-presentJean Bolognia has served as President of the Medical Dermatology Society, the Women’s Dermatologic Society and the American Dermatological Association, in addition to serving as Vice-President of the Society of Investigative Dermatology, the American Board of Dermatology, and the International Society of Dermatology. She has also been elected to serve on the Board of Directors of the American Academy of Dermatology and the International League of Dermatological Societies. In the latter organization, she currently serves as Secretary-General. Jean is the senior editor of the textbook Dermatology, which is now in its fourth edition, and Dermatology Essentials. She is also the co-founder of the Clinical Scholars program of the SID and author of over 200 articles and book chapters.
  • Former faculty

    Department: Pathology, Immunobiology (Primary); Molecular, Cellular and Developmental Biology (Secondary)Years active at Yale: 1980-2007Dr. Bottomly is being recognized for her work as a renowned immunobiologist responsible for fundamental discoveries in her field. She served as deputy provost at Yale and, from 2007 to 2016, was the 13th president of Wellesley College. She has published more than 170 refereed articles in science journals and holds six patents. She is an elected fellow of the American Academy of Arts and Sciences, the National Academy of Inventors, and the Connecticut Academy of Science and Engineering. She was awarded an honorary doctorate from Japan Women’s University and was selected as one of the University of Washington’s ‘Wondrous 100’ (top 100 graduates of the past century). In addition to recognition for strong leadership in excellence in all aspects of academia, Dr. Bottomly has a long-standing keen interest in science education and women in science. She chaired the board of directors of the Consortium on Financing Higher Education and was a member of the advisory council of the National Institutes of Allergy and Infectious Diseases at the National Institutes of Health. She is a member of the leadership council of the Yale School of Engineering and Applied Science and the Olin College of Engineering President’s Council. She currently serves as a trustee for the Woodrow Wilson Fellowship Foundation.
  • Former faculty

    Years active at Yale: PhD Class of 1996; 1992-2017 Dr. Bradley is being recognized for her teaching, mentoring, and leadership roles. She was Brady-Johnson Professor of Grand Strategy and founder and faculty director of the Yale Global Health Leadership Institute at Yale. In 2017, she became president of Vassar College.Dr. Bradley is regarded as being at the forefront of healthcare system strengthening, both domestically and internationally. She is co-author of the The American Healthcare Paradox: Why Spending More Is Getting Us Less, a book that started an international dialogue on the impact of social determinants on the health of a population. She led the Health Management Program at the Yale School of Public Health, Health Policy and Administration and coordinated health management teaching efforts in joint programs for business and medical students at Yale University. A leader of global health initiatives at Yale, she spearheaded education and research programs in China, the United Kingdom, Ethiopia, Ghana, Liberia, Rwanda, and South Africa. Her work in these countries contributed to significant changes to advance the overall health and well-being of their populations. In the U.S., she contributed to the improvement of quality of care within hospital settings, the understanding of the relationship between state-level social service spending and health outcomes, and improving the transition from acute to palliative care.
  • Professor of Emergency Medicine and of Anesthesiology and of Biostatistics; Director, Yale Center for Medical Informatics

    Years active at Yale: 1995-presentDr. Brandt is being recognized for her work building informatics infrastructure for clinical research and performing research focused on such issues as the management of clinical vocabularies used in clinical research databases and the implementation of computerized clinical practice guidelines. She is also part of an interdisciplinary team that received funding to develop the Pain Management Collaboratory Coordinating Center, which will provide national leadership and serve as a national resource in conducting high-impact pragmatic clinical trials on non-drug approaches to manage pain and other comorbid conditions in veteran and military health care systems.
  • Former faculty

    Years active at Yale: 1996-2007Dr. Bravata is being recognized for her achievements in research and mentorship. Dr. Bravata’s research has focused on the measurement and evaluation of quality of care, seeking to identify gaps in care that serve as targets for future implementation projects. Currently professor of medicine at the University of Indiana, she has published over 100 peer-reviewed research papers in leading journals. In 2006, Dr. Bravata became the clinical coordinator of the Department of Veterans Affairs (VA) Stroke Quality Enhancement Research Initiative, where she worked with collaborators in the U.S.and Canada to develop and advance a national VA stroke research health services, implementation science, and health policy portfolio. Dr. Bravata was the first to benchmark the quality of stroke care for patients in VA hospitals in a study that identified opportunities to improve VA stroke care. This project led to the issuance of the national VA Acute Ischemic Stroke Directive and to system-wide changes in the organization of VA stroke services. As a result of this system reorganization, stroke care quality has improved consistently and substantially for veterans.Her work in stroke care quality led to an interest in evaluating new approaches to improve outcomes for patients with vascular disease. For example, she has conducted several prospective, randomized controlled clinical trials to evaluate a strategy of diagnosing and treating sleep apnea among patients with a cerebrovascular event. These studies demonstrated that this strategy results in clinically meaningful improvements in neurological functioning and a reduced risk of recurrent vascular events for patients with stroke and transient ischemic attack. Dr. Bravata has also served as a research mentor for many students, fellows, and junior faculty members across a diverse spectrum of clinical specialties.
  • Former faculty

    Department: Department of Human GeneticsYears active at Yale: 1974-1984Dr. Breakefieldis being recognized for her international leadership in the field of the genetics and gene therapy of brain tumors. She has been at the forefront of research on gene therapy for brain tumors, including such novel killing mechanisms as prodrug-activating enzymes delivered by oncolytic virus vectors and neuroprecursor cells as homing vehicles for delivery of therapeutic proteins. She has also led efforts in new methods of in vivo molecular imaging of gene delivery and tumor regression, and modulation of microRNAs in tumors and associated endothelial cells to kill tumor stem cells and block angiogenesis. She and her colleagues are now characterizing the role of exosomes produced by tumor cells in the manipulation of normal tissue to promote tumor expansion and as serum biomarkers to monitor tumor status.She is now at Harvard, where she is a professor of neurology and a geneticist in the neurology and radiology services at Massachusetts General Hospital. Dr. Breakefield is a member of Scientific Advisory Board at Exosome Diagnostics, Inc. She has served on the National Institutes of Health Recombinant DNA Advisory Committee and is a member of an NIH study section that reviews translational research.
  • Former faculty

    Department: Internal MedicineYears active at Yale: Late 1980's-2001Dr. Brett-Smith is being recognized because of her excellence in clinical work, specifically in HIV/AIDS. After completion of her residency and infectious disease fellowship at Yale, Dr. Brett-Smith specialized in the care of HIV patients and became a passionate advocate for these patients. She was the first medical director of the HIV clinic at the Hospital of St.Raphael, called the Haelen Center Infectious Disease. She worked tirelessly to care for patients with AIDS early in the epidemic when many others were avoiding these patients. In addition to her devotion to clinical care, Dr. Brett-Smith was also an outspoken advocate for all issues relating to women and women’s rights.
  • Professor of Medicine (Nephrology); Training Program Director, Nephrology Fellowship

    Years active at Yale: 1998-presentDr. Brewster is being recognized for several reasons. The first is her teaching and mentoring. She is a tremendous teacher of the resident physicians, always going above and beyond to teach on rounds, at the bedside, and in formal teaching sessions. Her teaching inspires passion within the residents and her energy and enthusiasm is palpable. She is a mentor to residents in multiple ways. Her patients absolutely adore her and she epitomizes the doctor-patient relationship. Watching her interact with patients inspires residents to be better clinicians. She is also a terrific example of a strong woman in medicine. She is not afraid to speak up and ensure that her patients get only the best care. Residents who watch Dr. Brewster stand up for her patients learn to do this themselves. Her teaching, modeling of the doctor-patient relationship, and passion for medicine are inspiring.
  • Associate Professor; Director, VACHS Center of Excellence in Primary Care Education

    Years active at Yale: 1999-2004; 2009-presentDr Brienza is being recognized for her leadership in the development and implementation of the Center of Excellence (COE) in Primary Care Education at VA ConnecticutHealthcare System. The COE is an innovative model of interprofessional education and team-based collaborative care. Dr Brienza was successful in receiving one of five competitive grants to develop this program in 2011 and since then has been a pioneer and strong advocate for the advancement of inter-professional education. The COE has developed many educational innovations that have been adopted throughout VA primary care as well as across the Yale internal medicine residency program. These have included the MD residents ambulatory immersion block schedule; the IMPROVE clinic, an interprofessional education and care initiative aimed at reducing polypharmacy in the elderly; integration of physical therapy into primary care teams; a robust quality improvement program; a health policy curriculum; numerous regional and national presentations,and the first interprofessional nurse practitioner residency program (now adopted by all COE sites). The COE program has included Yale internal medicine residents and medical students; Yale nurse practitioner students and post-graduate residents; health psychology pharmacy and social work residents;and Yale Physician Associate students. As director of this program, Dr Brienza has served as a mentor, role model,and leader to all trainees.
  • Former faculty

    Department: Pediatric CardiologyYears active at Yale: 1950s-early 1990sDr. Brown is being recognized as one of the earliest pediatric cardiologists. She worked with Dr. Ruth Whittemore, and together they set up and ran the first EKG laboratory for children. They traveled throughout Connecticut to set up clinics so that sick children didn’t have to travel to New Haven for care. Dr. Brown was one of the first people to catalog the children of people who had congenital heart disease and to establish that there was a higher risk for offspring who had been born to parents with congenital heart disease. Even before cardiac catheterization, Dr. Brown worked with early pioneering pediatric heart surgeons for children.Dr. Brown was also known for her teaching and mentoring of medical students.
  • Professor of Pediatrics (Cardiology)

    Years active at Yale: 1990-presentDr. Brueckner is being recognized for excellence in clinical medicine and research. She obtained her BS and MD degrees from the University of Virginia, followed by a pediatric residency at the University of Pittsburgh and a pediatric cardiology fellowship at YSM. Her clinical and research focus is genetics of congenital heart disease (CHD). Her laboratory focuses on the cause(s) of a type of congenital heart disease called heterotaxy. The development of non-random asymmetry along the left-right axis is a unique feature of vertebrate development. Defects in this process in mouse and man result in severe congenital cardiac anomalies. The goal of Dr. Brueckner’s laboratory is to understand the mechanism by which embryonic cilia create and signal left-right positional information, and to investigate whether cilia have essential roles in other developmental processes. In addition to her studies of mouse models of congenital heart disease, Dr. Brueckner is developing a large-scale international collaboration using state of the art genomic technology to identify the genes causing heterotaxy in humans.
  • Former faculty

    Years active at Yale: 1964-1994Dr. Buckley is being recognized for her contributions to science. She was a virologist at Johns Hopkins, then the Rockefeller virus labs before they were moved to Yale to form the Yale Arbovirus Research Unit. With Dr. Wilbur Downs and Dr. Jordi Casals-Ariet at Yale, Dr.Buckley was credited with isolating and cultivating the Lassa virus responsible for outbreaks of hemorrhagic fever in Africa.
  • Professor of Medicine (Medical Oncology); Interim Associate Cancer Center Director, Diversity, Equity, and Inclusion; Chief, Head and Neck Cancers/Sarcoma; Disease Aligned Research Team Leader, Head and Neck Cancers Program; Co-Leader, Developmental Therapeutics, Yale Cancer Center

    Years active at Yale: 1989 - presentDr. Burtness is being recognized for a pioneer clinical study of epidermal growth factor (EGFR) inhibition. As part of that study, she administered the first-in-human dose of cetuximab, an antibody that leads the cell to degrade the EGFR, at Yale in 1995.In her role as chair of the ECOG-ACRIN Oncology Group Head and Neck Therapeutics Committee, Dr. Burtness led the field in studying (human papillomavirus) HPV-driven head and neck cancer as a distinct disease, and pioneered the study of treatment deintensification. She introduced bevacizumab into treatment of metastatic disease, and established the first cooperative group trial of minimally invasive surgery for HPV-driven disease. She led the pivotal trial establishing immune checkpoint blockade as first-line therapy for recurrent-metastatic head and neck cancer, leading to FDA approval. She is Director of the Yale Head and Neck Specialized Program of Research Excellence. Her laboratory studies synthetic lethal strategies for HPV-negative head and neck cancer and the role of aurora kinase A in adaptive resistance to EGFR or ras inhibition. Dr. Burtness has mentored many oncologists who are now important leaders in the field of head and neck cancer. She received the Robert L. Krigel Award for Excellence in Teaching and Clinical Oncology from the Fox Chase Cancer Center in 2012, and was named Top Doctor in U.S. News and World Report. She serves as Interim Associate Director for Diversity, Equity and Inclusion at Yale Cancer Center.
  • Professor of Public Health (Health Policy) and Professor in the Institution for Social and Policy Studies

    Years active at Yale: 2000-presentDr. Busch is being recognized for teaching and policy research. She leads impactful research examining the effects of policies and regulations on health care cost and quality. Most of her work focuses on behavioral health; health care economics and organizations; health services research; and health care quality, access, and evaluation.As the opioid epidemic deepens, Dr. Busch’s research on opioid addiction becomes more integral to treatment options and effectiveness. Her most recent work identified that people with opioid addiction who seek treatment in emergency departments (ED) for overdoses and other ailments and receive buprenorphine, a medication to reduce drug cravings, incur lower health care costs over the following month than those who get a referral to treatment services or receive a brief intervention with a facilitated referral. The findings are significant because relatively few people with opioid use disorder receive treatment, and even fewer receive the most effective treatments such as buprenorphine. Additionally, patients who started the medication in an ED were almost twice as likely to be enrolled in addiction treatment and used opioids for fewer days, during the 30 days following their ED visits. The findings could have a significant impact in Connecticut, where emergency departments treat a relatively high number of opioid-related cases.
  • Associate Professor of Emergency Medicine; Associate Director of Pediatric Programs, Yale Program in Addiction Medicine

    Years active at Yale: 2012-presentDr. Camenga is being recognized for her innovative work as a physician-scientist with expertise in adolescent addiction, smoking cessation, and young adult e-cigarette use. She is a recent graduate of the National Institute on Drug Abuse K12 scholar program at Yale. She was recently selected to serve on a national American Academy of Pediatrics Committee on Substance Use and Prevention, tasked with protecting and improving the health and well-being of children and adolescents throughout the country. She is one of a very few clinicians in the state that provides medication treatment for adolescents and young adults with opioid use disorder.
  • Years active at Yale: 1990-presentDr. Camp is being recognized for her career as an endocrinologist dedicated to improving the care of people with diabetes and metabolic disease in underserved communities, specifically at the Fair Haven Community Health Center in New Haven. Over the last decade, as the incidence of diabetes explodes in the population she serves, her focus has broadened to include research in diabetes prevention and improved treatments that address the needs of such communities. Following medical school at Vanderbilt she completed residency in Internal Medicine at Yale, followed by fellowships in preventive cardiology and endocrinology. Under her leadership, the Fair Haven Community Health Center was among the first nationally to focus on health disparities in diabetes incidence and outcomes. She has worked tirelessly to improve diabetes care for the underserved through applied organizational system changes. More recently, her efforts have been directed at developing such systems as translating existing evidence into proven effective programs. These are aimed at reversing abnormalities in glucose regulation in adults with pre-diabetes and obese youth in underserved communities. Her current research collaboration through the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases takes place within a multicenter clinical trial to evaluate and compare the long-term metabolic and clinical effects of several classes of drugs in combination with metformin for the treatment of type 2 diabetes.
  • Alumna

    Years active at Yale: YSPH Class of 1998 Andy Carmone is being recognized for her dedication to and excellence in public health. She has lived and worked in low-income communities for multiple years, despite hardship and sacrifice, both personal and professional. Trained as a nurse midwife and public health professional, she offers a unique perspective on health systems design and evaluation and global health delivery, particularly among rural and remote populations. She has over 20 years of experience in resource-limited settings such as: Cameroon, Cambodia, India, Indonesia, Malawi, the Navajo Nation, Papua New Guinea, and New Mexico (U.S.). She has worked intensively to design public health interventions that focus on the decentralization of high-quality HIV, TB, maternal, and child health, as well as conduct research and leverage evidence to inform policy. She was instrumental in developing research to improve clinical outcomes and the quality of care for thousands of women, children, and families across Papua New Guinea and Indonesia.Since 2006, Carmone has been engaged in efforts to rebuild health systems in the Highlands of Papua New Guinea, some of the most remote populations in the world. Her work spans technical assistance and guidance to local and international health programs, including guidance on protocols, tools, and technology adoption in areas such as family health, essential medicines, vaccine delivery, HIV, TB, and women's sexual and reproductive health. She has co-authored papers in a variety of peer-reviewed journals including the Journal of AIDS. She serves as clinical director on the Clinton Health Access Initiative's Clinical Sciences Team and is also the co-founder of Indigenous Health Solutions, a non-profit organization focused on integrated delivery of health, development, and conservation programs in Papua New Guinea.
  • Professor Emeritus of Orthopaedics and Rehabilitation

    Years active at Yale: 1986-presentDr. Gundberg is being recognized for advocating for women. She was active on the Committee for the Status of Women in Medicine (SWIM) for years and was on the Commission on Women Faculty that resulted from the Bill of Rights. She evaluated space allotment to faculty by gender.
  • Professor of Surgery (Oncology, Breast); Affiliated Faculty, Yale Institute for Global Health

    Years active at Yale: 2010-present; MBA Class of 2014Dr. Chagpar is being recognized for her numerous groundbreaking innovative clinical and translational studies in breast cancer. Born and raised in Canada, she completed her MD with honors in research at the University of Alberta, and her general surgery residency training and MSc at the University of Saskatchewan. She went on to complete the Susan G. Komen Interdisciplinary Breast Fellowship at the University of Texas M.D. Anderson Cancer Center, an MPH at Harvard School of Public Health and an MA in bioethics and medical humanities at the University of Louisville. After fellowship, she joined the University of Louisville as assistant professor of surgery, rising rapidly through the ranks to associate professor with tenure and academic advisory dean. She built the first nationally accredited Breast Center in Kentucky at the James Graham Brown Cancer Center prior to being recruited to Yale in September 2010, where she led the effort for Yale to become the first NCI-designated Comprehensive Cancer Center in the Northeast to have a nationally accredited breast center. She is a busy breast surgical oncologist who participates in investigator-initiated and cooperative group clinical trials, as well as translational and clinical research. Her most recent groundbreaking work was published in the prestigious New England Journal of Medicine. She enjoys teaching and mentoring medical students, residents, fellows, and junior faculty, and is the Breast Surgery Section editor for UpToDate, a commonly used resource. She is passionate about global health and leadership in academic medicine, having most recently completed an MBA for Executives with a focus on Leadership in Healthcare at Yale’s School of Management.
  • Professor of Medicine (General Medicine); Associate Dean for Student Research, Office of Education; Co-Director, National Clinician Scholars Program

    Years active at Yale: 2005-presentDr. Chaudhry is being recognized for her excellence in outcomes and health services research and mentoring. She is Associate Dean of Student Research, founding director of the Center for Healthcare Innovation, Redesign, and Learning (CHIRAL), and co-director of the National Clinician Scholars Program. Her scholarly work has focused on improving the care and outcomes of older patients in the hospital setting, especially those with cardiovascular disease. In addition to directing large-scale epidemiologic studies, she has led work to understand and improve care transitions in the hospital setting. Her work has been published in leading medical journals and she has excelled as a nationally and internationally recognized thought leader in her field. Dr. Chaudhry is a standing member of the Health Services, Organization and Deliver study section for the National Institutes of Health (NIH). She has mentored numerous medical students, residents, fellows, and junior faculty, who have garnered awards that include career development awards from the NIH and American Heart Association.
  • Associate Professor of Emergency Medicine; Medical Director, Patient Experience, Emergency Medicine; Affiliated Faculty, Yale Institute for Global Health; Medical Director, PA/NP group; Medical Director, Yale New Haven Hospital PA/NP Residency Program; Faculty Member, Division of Global Health and International Emergency Medicine; Chair, Patient Experience Forum

    Years active at Yale: 2007-presentDr. Chekijian is being recognized for her insightful clinical expertise, her extraordinary compassionate worldview and sensitivity for her patients, and her ability to impart these qualities to all caregivers including students, residents, advanced practice providers, faculty, and nurses. She is the director of patient experience in the Department of Emergency Medicine (EM) and is committed to bettering patient and staff communication and engagement. She isthe founding medical director of the PA residency program in EM, the first postgraduate PA program at Yale School of Medicine. She has been instrumental in the development of a bereavement program in the emergency department, and is known internationally for her emergency care systems development, unintentional injury prevention, and cardiac care in low- and middle-income countries. She is deeply committed to spearheading the development of injuryprevention programs in Armenia and she has served as a consultant for the World Bank and the U.S. Department of State.
  • Professor of Neurosurgery; Assistant Dean for Admissions, Medical Education; Associate Vice Chair of Academic Affairs; Director, Stereotactic Radiosurgery; Director, Gamma Knife Center, YNHH; Director, Stereotactic Radiosurgery Fellowship

    Years active at Yale: 1994-presentDr. Chiang is being recognized for being the first female physician to become a full professor in the Department of Neurosurgery at Yale School of Medicine. Dr. Chiang pioneered the use of laser thermocoagulation therapy for brain metastases and now directs the Intra-operative MRI Laser Program for patients with brain tumors and epilepsy at YSM. She is also director of the Yale New Haven Hospital Gamma Knife Radiosurgery Program and a tireless mentor to women in Neurosurgery.
  • Professor of Biostatistics; Director of Medical Research, School of Public Health

    Years active at Yale: 1988-present; PhD Class of 1988, MD Class of 1994Dr. Claus is being recognized for her work in basic and clinical science, as well as her teaching, mentoring, clinical care and expertise, and leadership. She is professor and director of medical research at the Yale School of Public Health, as well as attending neurosurgeon and director of stereotactic radiosurgery in the Department of Neurosurgery at Brigham and Women’s Hospital in Boston. She is a member of the board of advisors for the Acoustic Neuroma Association, as well as the Central Brain Tumor Registry of the United States. Dr. Claus’ work focuses on cancer and genetic epidemiology, with an emphasis on the development of risk models for breast and brain tumors. She is the PI of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study, as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control projects. In addition to her research activities, Dr. Claus is a board-certified neurosurgeon who completed her residency in neurosurgery at Yale New Haven Hospital and her fellowship in neurosurgical oncology Brigham and Women’s Hospital. Her clinical focus is on the treatment of meningioma, glioma, acoustic neuroma, and brain metastases. In partnership with national patient brain tumor organizations, Dr. Claus is working to develop cost- and time-efficient web- and smartphone- based recruitment strategies to be used in the study of brain tumors.
  • Former faculty

    Department: Office of Women in MedicineYears active at Yale: 1980-1986Dr. Codish is being recognized as the first administrative director and subsequently director of the Office for Women in Medicine. She drafted YSM’s first sexual harassment policies for faculty and convened the schools’ Permanent Committee on the Status of Women. She was a founding member of the Women’s AIDS Coalition as well as director of education and volunteer services at AIDS Project New Haven for many years. She was known for her lifetime commitment to social justice. In 1970, she and two friends founded the Theatre of Light and Shadow, which brought such issues as rape, battering, abortion rights, sexual harassment,and later HIV/AIDS to audiences across the country. She formed the Women’s Self Defense Alliance in the early 1970s and initiated the first of many Women’s Health Weekends and Take Back the Night marches in New Haven. After leaving Yale, Dr. Codish headed the New Haven Police Academy and the police department’s division of training and education. She advised other police departments on recruiting and retaining women and people of color. She encouraged the department to develop a new breed of community-based police officers and switch from a military to a problem-solving philosophy. Her department was considered a model across the country. The National Center for Women and Policing presented her with an innovative policing award, and in 1985, she won the Elm Ivy Award, which honors people whose efforts support the collaboration of the university and its hometown.
  • Professor Emeritus of Pediatrics

    Years active at Yale: 1998-2018Dr. Colson is being recognized for her absolute commitment to the full mission of the School of Medicine’s educational scholarship and advocacy, clinical excellence, nationally recognized research program, and local and national leadership. Dr. Colson, a Macy Scholar, is fully invested in the educational mission of the school, not only leading clinical education for the Department of Pediatrics, but also co-founding and leading the Interprofessional Longitudinal Clinical Experience, which brings together medical students, physician associate students, and advanced practice nursing students. She is recognized as a local and national expert in educational and clinical scholarship, and is a go-to resource for anyone in the Department of Pediatrics who is considering qualitative methods. Dr. Colson is a tireless advocate for her colleagues and mentor to her juniors, and has served on school-wide committees for faculty engagement, faculty culture, and for status of women in medicine.In 2018, Dr. Colson left Yale to become the Professor and Associate Dean, PE/CQI at Washington University in St. Louis School of Medicine.
  • Dean of the Graduate School of Arts and Sciences; C. N. H. Long Professor of Genetics and Professor of Cell Biology and of Molecular, Cellular, and Developmental Biology

    Years active at Yale: 2001-presentDr. Cooley is being recognized for her seminal research into understanding the biology of germ cells, which are the only cells in our bodies that can form eggs or sperm to transmit genetic information to the next generation. She is also Dean of the Graduate School of Arts and Sciences.Dr. Cooley, the C.N.H. Long Professor of Genetics and Professor of Cell Biology and of Molecular, Cellular, and Developmental Biology, was the Director of the Combined Program in the Biological and Biomedical Sciences before becoming the dean. She is a member of the Connecticut Academy for Science and Engineering and a fellow for the American Association for the Advancement of Science. Dr. Cooley is also the recipient of a Pew Scholar Award from the Pew Charitable Trusts, in 1991.Dr. Cooley’s current research is focused on intercellular bridges, called ring canals that connect cells as they form eggs or sperm. Ring canals are present in germ cells throughout the animal kingdom, from insects to humans. This conservation over millions of years of evolution suggests ring canals provide an important advantage to the process of germ cell development. Dr. Cooley’s lab uses Drosophila (fruit flies) to investigate ring canal function. The Cooley lab has documented extensive sharing of cellular components through ring canals in both males and females. Her lab is now investigating how ring canals form in the first place, how they are stabilized and the kinds of information shared through ring canals.
  • Professor of Psychiatry; Associate Dean for Gender Equity, Yale School of Medicine; Director, Office for Women in Medicine and Science, Yale School of Medicine; Deputy Chair for Diversity, Equity and Inclusion, Psychiatry; Director, Program Evaluation and Child Trauma Research at The Consultation Center

    Years active at Yale: 2001- presentDr. Crusto is being recognized for excellence in her leadership role addressing culture, context, and human diversity in clinical work and community. She is a professor and assistant chair for diversity in the Department of Psychiatry, associate dean for gender equity and director of the Office for Women in Medicine and Science, and the director of program evaluation and child trauma research at The Consultation Center. She is an expert in culture and diversity affecting work, community, research, and program evaluation. She chaired a task force in the American Evaluation Association that developed practice guidelines for addressing culture and context in the profession and in the provision of evaluation services to the public and to evaluation consumers. She is the assistant chair for diversity in the Department of Psychiatry and the chair of the psychology section committee on diversity, equity and inclusion. Dr. Crusto is known for her work in community-engaged research, program evaluation and research, and intervention work in children’s exposure to psychological trauma, particularly childhood exposure to intimate partner violence and its impact on their health and wellbeing. Dr. Crusto was a visiting scholar and an extraordinary professor at the University of Pretoria in South Africa. She mentors psychology pre-doctoral fellows, post-doctoral fellows, psychiatry residents, and medical students. Using <em>“Making the Invisible Visible,”</em> a 3-hour guided museum tour, Dr. Crusto mentors Yale medical students to help them develop, implement, and evaluate art observation to facilitate dialogue about biases and their influence on personal and professional interaction.
  • Professor Emeritus of Radiology and Biomedical Imaging; NIOSH Certified B Reader

    Years active at Yale: YSM Class of 1970; 1970-presentDr. Curtis is recognized for her expertise in diagnostic imaging, her skilled teaching, and her advocacy for—and mentoring of—women at YSM. After her internship and residency at Yale New Haven Hospital. Dr Curtis joined the faculty in 1975 as an assistant professor of diagnostic radiology, becoming a full professor in 1985. Dr. Curtis has long championed the cause of women at the school. She has worked to recruit female faculty and students since the late 1970s as director of the Office for Women in Medicine, and then as chair of the Committee on the Status of Women in the School of Medicine. In 1990, she received the Leah Lowenstein Award for promoting humane and egalitarian medical education. Dr. Curtis has lent her talents to numerous panels, including the Dean’s Ad Hoc Grievance Committee, the Senior Appointment and Promotions Committee, and the Medical Students Thesis Awards Committee. She has also sat on numerous committees at YNNH and is past president of its medical board. Her skills in diagnostic imaging have had her delivering lectures and courses in such places as Kentucky, Venezuela, and Utah. Dr. Curtis’s professional services include being a reviewer for the American Journal of Radiology. In the community, she has been a longtime member of the board of directors of the Neighborhood Music School.
  • Albert E. Kent Professor of Emergency Medicine, Professor of Epidemiology (Chronic Diseases) and Professor of Medicine Core Addiction

    Years active at Yale: 1997- presentDr. D’Onofrio is being recognized as one of the nation’s foremost experts in emergency medicine, substance use disorders, and heart disease in women. She is also one of only a handful of academic leaders in her field. In 2009, Dr. D’Onofrio was named physician-in-chief of the Emergency Department (ED) at Yale New Haven Hospital as well as the inaugural chair of the Department of Emergency Medicine. She is internationally known for her work in screening emergency department patients for alcohol and drug use and directing them to treatment. Her work has grown in importance during the nation’s opioid crisis as she has led clinical trials demonstrating that administering buprenorphinein the emergency department increases patient participation in addiction treatment. Dr. D’Onofrio is one of the architects of the state of Connecticut’s strategic plan to reduce opioid deaths, working with multiple agencies regionally and nationally to change policies and introduce interventions to stem the crisis.Dr. D’Onofrio’s research has changed clinical practice and led to multiple science awards from the Hazelden Betty Ford Foundation and the Clinical Research Forum. In 2018, she was appointed to the National Advisory Council on Drug Abuse and she was selected to present the keynote speech at the Society for Academic Emergency Medicine (SAEM) national conference. Additionally, the Yale DEM received the Outstanding Department Award from the Academy for Women in Academic Emergency Medicine (AWAEM) which honors her department’s outstanding support of women in academic emergency medicine through organizational initiatives that address the recruitment, development and advancement of its women physicians, promoting gender equality, diversity, opportunity and inclusion. Dr. D’Onofrio is also a dedicated teacher and mentor, having won the Advancing Women in Emergency Medicine award from SAEM.